Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Intuitive Surgical price target lowered to $530 from $625 at JPMorgan
JPMorgan expects shares of Intuitive Surgical to be in the "penalty box" for a quarter or two after it cuts its outlook, said additional Japan reimbursement is unlikely in 2014, and announced an FDA warning letter. However, the firm believes catalysts are in place to drive future growth and keeps an Overweight rating on Intuitive Surgical, despite lowering its price target for shares to $530 from $625.
Terms and Privacy Policy